Manganese-bilirubin effect on cholesterol accumulation in rat bile canalicular membranes

Toxicological Sciences

Volumn 53, Issue 1, 2000, Pages 150-155

  Duguay, Alexandra B ^a   Yousef, Ibrahim M ^a   Plaa, Gabriel L ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Bilirubin; Cholestasis; Cholesterol; Manganese; Membrane

Indexed keywords

BILIRUBIN; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MANGANESE; MEVALONIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTASIS; CONTROLLED STUDY; ENZYME ACTIVITY; INTRAHEPATIC BILE DUCT; MALE; MEMBRANE; NONHUMAN; RAT; SPECTROPHOTOMETRY;

EID: 0033971363     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/53.1.150     Document Type: Article

References (42)

1. Ayotte, P., and Plaa, G. L. (1985). Hepatic subcellular distribution of manganese in manganese and manganese-bilirubin induced cholestasis. Biochem. Pharmacol. 34, 3857-3865.
2. Bertolotti, M, Loria, P., Carubbi, F., Bozzoli, M, Dilengite, M.A., and Carulli, N. (1995). Biochemical methods to study hepatic cholesterol metabolism. In Methods in Biliary Research (M. Muraca Ed.), pp. 81-98. CRC Press, Boca Raton.
3. Crawford, J. M., Möckel, G. M., Crawford, A. R., Hagen, S. J., Hatch, V. C, Bames, S., Godleski, J. J., and Carey, M. C. (1995). Imaging biliary lipid secretion in the rat: ultrastructural evidence for vesiculation of the hepatocyte canalicular membrane. J. Lipid Res. 36, 2147-2163.
4. Dahlström-King, L., and Plaa, G. L. (1989). Effect of inhibition of protein synthesis on cholestasis induced by taurolithocholate, lithocholate, and a manganese-bilirubin combination in the rat. Biochem. Pharmacol. 38,2543-2549.
5. de Lamirande, E., and Plaa, G. L. (1979). Dose and time relationships in manganese-bilirubin induced cholestasis. Toxicol. Appl. Pharmacol. 49, 57-263.
6. de Lamirande, E., Tuchweber, B., and Plaa, G. L. (1981). Hepatocellular membrane alteration as a possible cause of manganese-bilirubin-induced cholestasis. Biochem. Pharmacol. 30, 2305-2312.
7. de Lamirande, E., Tuchweber, B., and Plaa, G. L. (1982). Morphological aspects of manganese-bilirubin induced cholestasis. Liver 2, 22-27.
8. DeGrella, R. F., and Simoni, R. D. (1982). Intracellular transport of cholesterol to the plasma membrane. J. Biol. Chem. 257, 14256-14262.
9. Duguay, A., and Plaa, G. L. (1997). Ketone potentiation of intrahepatic cholestasis: effect of two aliphatic isomers. J. Toxicol. Environ. Health SO, 41-52.
10. Duguay, A., Yousef, I. M., Tuchweber, B., and Plaa, G. L. (1998). Alteration of lipid composition of hepatic membranes associated with manganesebilirubin induced cholestasis. Fundam. Clin. Pharmacol. 12, 213-219.
11. Feuer, G., and Di Fonzo, C. J. (1992). Intrahepatic cholestasis: a review of biochemical-pathological mechanisms. Drug Metab. Drug Interact. 10, 1-165.
12. Kaplan, M. R., and Simoni, R. D. (1985). Transport of cholesterol from the endoplasmic reticulum to the plasma membrane. J. Cell. Biol. 101, 446-453.
13. Kunze, D., and Riistow, B. (1993). Pathobiochemical aspects of cytoskeleton components. Eur. J. Clin. Chem. Clin. Biochem. 31, 477-489.
14. Lange, Y., and Matthies, H. J. (1984). Transfer of cholesterol from its site of synthesis to the plasma membrane. J. Biol. Chem. 259, 14624-14630.
15. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
16. Maxwell, J. D., and Williams, R. (1973). Drug-induced jaundice. Br. J. Hasp. Med. 9,193-200.
17. Mclntyre, J. C., and Sleight, R.,G. (1994). Mechanisms of intracellular membrane lipid transport. Curr. Topics Membranes 40, 453-481.
18. Plaa, G. L., and Priestly, B. G. (1976). Intrahepatic cholestasis induced by drugs and chemicals. Pharmacol. Rev. 28, 207-273.
19. Plaa, G. L., de Lamirande, E.; Lewittes, M., and Yousef, I. M. (1982). Liver cell plasma membrane lipids in manganese-bilirubin induced intrahepatic cholestasis. Biochem. Pharmacol. 31, 3698-3701.
20. Plaa, G. L., Duguay, A. B., King, L. M., and Hewitt, W. R. (1998). Cholestasis produced by combinations of manganese and bilirubin. In Toxicology of the Liver (G. L. Plaa and W. R. Hewitt, Eds.), 2nd edition, pp. 383-400. Taylor & Francis, Washington, DC.
21. Reinhart, M. P. (1990). Intracellular sterol trafficking. Experienlia 46, 599-610.
22. Reinhart, M. P., Billheimer, J. T., Faust, J. R., and Gaylor, J. L. (1987). Subcellular localization of the enzymes of cholesterol biosynthesis and metabolism in rat liver. J. Biol. Chem. 262, 9649-9655.
23. Roy, C., Tuchweber, B., Weber, A., and Yousef, I. M. (1989). Update on bile formation and on mechanism of bile acid induced cholestasis. In Modem Concepts in Gastroenlerology (E. Schaffer and A. B. R. Thomson, Eds.). Vol. 2, pp. 41-67. Plenum Press, New York.
24. +-ATPase activities of canalicular-enriched rat liver plasma membranes. Gastroenlerology 74, 1183-1190.
25. Sandermann, H. (1978). Regulation of membrane enzymes by lipids. Biochim. Biophys. Ac/a. 515, 209-237.
26. Schwarz, L. R., Schwenk, M., Pfaff, E., and Greim, H. (1977). Cholestatic steroid hormones inhibit taurocholate uptake into isolated rat hepatocytes. Biochem. Pharmacol. 26, 2433-2437.
27. Sherlock, S. (1970). Effects of drugs on the liver. Ann. Clin. Biochem. 7, 75-80.
28. Spector, A. A., and Yorek, M. A. (1985). Membrane lipid composition and cellular function. J. Lipid. Res. 26, 1015-1035.
29. Sperry, W. M., and Webbs, M. (1950). A revision of the Schoenheimer-Sperry method for cholesterol determination. J. Biol. Chem. 187, 97-106.
30. Steiner, J. W., Jézéquel, A., Phillips, M. J., Miyai, K., and Arakawa, K. (1965). Some aspects of the ultrastructural pathology of the liver. In Progress in Liver Disease (H. Popper and F. Schaffner, Eds.), Vol. 2, pp. 303-372. Grune & Stratton, New York.
31. Sturgill, M. G. and Lambert, G. H. (1997). Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function. Clin. Chem. 43, 1512-1526.
32. Tanner, A. R. (1986). Hepatic cholestasis induced by trimethoprim. Br. Med. J. 293, 1072-1073.
33. Tuchweber, B., Weber, A., Roy, C. C., and Yousef, I. M. (1986). Mechanisms of experimentally induced intrahepatic cholestasis. In Progress in Liver Disease (H. Popper and F. Schaffner, Eds.), Vol. 8, pp. 161-178. Grune & Stratton, New York.
34. Urbani, L., and Simoni, R. D. (1990). Cholesterol and vesicular stomatitis virus G protein take separate routes from the endoplasmic reticulum to the plasma membrane. J. Biol. Chem. 265, 1919-1923.
35. Verhamme, M., Ramboer, C., Van de Bruaene, P., and Inderadjaja, N. (1989). Cholestatic hepatitis due to an amoxycillin/clavulanic acid preparation. J. Hepatol. 9, 260-264.
36. Vore, M. (1987). Estrogen cholestasis: membranes, metabolites, or receptors? Gastroenterology 43, 643-649.
37. Witzleben, C. L. (1972). Physiologic and morphologic natural history of a model of intrahepatic cholestasis (magnanese-bilirubin overload). Am. J. Palhol. 66, 577-588. -
38. Yeagle, P. L. (1991). Modulation of membrane function by cholesterol. Biochimie 73, 1303-1310.
39. Yousef, I. M., and Tuchweber, B. (1984). Effect of lithocholic acid on cholesterol synthesis and transport in rat liver. Biochim. Biophys. Ada. 796, 336-344.
40. Yousef, I. M., Lewittes, M., Tuchweber, B., Roy, C. C., and Weber, A. (1984). Lithocholic acid-cholesterol interactions in rat liver plasma membrane fractions. Biochim. Biophys. Ada. 796, 345-353.
41. Yousef, I. M., Tuchweber, B., and Weber, A. (1983). Prevention of lithocholate-induced cholestasis by cycloheximide, an inhibitor of protein synthesis. Life Sci. 33, 103-110.
42. Zimmerman, H. J. (1998). Drug-induced hepatic disease. In Toxicology of the Liver (G. L. Plaa and W. R. Hewitt, Eds.), 2nd edition, pp. 3-60. Taylor & Francis, Washington, DC.